Process for isolating nucleated cells and nucleated cell populations and uses thereof

A technology for nucleated cells and non-nucleated red blood cells, used in the field of separation of nucleated cells and nucleated cell populations and its applications, can solve the problems of difficult to achieve reliable and reproducible separation

Pending Publication Date: 2019-03-01
MESOTEX INC
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although various fetal cell types have been isolated from maternal blood, such as trophoblasts, leukocytes, nucleated erythrocytes, platelets, and hematopoietic progenitors, most types of fetal cells or combinations of fetal cells present in maternal blood are reliably and reproducibly The separation of the seemingly elusive goal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for isolating nucleated cells and nucleated cell populations and uses thereof
  • Process for isolating nucleated cells and nucleated cell populations and uses thereof
  • Process for isolating nucleated cells and nucleated cell populations and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0178] 6.1 Example 1: Isolation of nucleated cells from maternal blood

[0179] Fluorinert TM FC-43 filled with 8cm diameter lumen figure 1 Separators of the type shown in . 25 mL of peripheral blood obtained from a pregnant female was combined with 25 mL of RPMI medium containing 2% dextran (w / v) to obtain a mixture with a final dextran concentration of 1%. The mixture was introduced through the top inlet / outlet into the lumen of the separation device atop FC-43 located in the lower part of the cylindrical part of the separation device and separated under local gravity into a nucleated cell-enriched fraction and Enucleated erythrocyte enriched fraction. Additional FC-43 was then introduced into the lumen via the bottom inlet / outlet, while the nucleated cell enriched fraction was collected from the top inlet / outlet.

[0180] Use the nucleated cell-enriched fraction for a second isolation to deplete remaining enucleated erythrocytes. After the first separation, the nucleat...

Embodiment 2

[0184] 6.2 Example 2: Isolation of a population of nucleated cells of interest

[0185] Maternal blood samples from normal pregnant females at 11-14 weeks of gestation were processed as described in Example 1 to obtain a nucleated cell enriched fraction. Then use RosetteSep TM Human Mesenchymal Stem Cell Enrichment Mixture (Stemcell Technologies) (Stemcell Technologies) followed by density gradient centrifugation, or non-physiological conditions followed by density gradient centrifugation to negatively select the nucleated cell enriched fraction for further fetal enrichment Nucleated cells. The medium used for non-physiological conditions contained sodium citrate, citric acid and glucose and had an osmolarity of 310-320 m mOsm / l.

[0186]

[0187] Table 2: Cell Recovery from Maternal Blood with RBC Batch Depletion and Further Enrichment of Fetal Nucleated Cells

[0188] Then, as described in Peters et al., 2010, PLoS ONE 5(12):e15689, in a complex containing human stem c...

Embodiment 3

[0189] 6.3 Example 3: Target Nucleated Cell Culture and Analysis

[0190] Maternal blood samples from 11-week-pregnant females carrying twins were processed according to the batch erythrocyte depletion strategy in section 5.5.1 to provide a nucleated cell-enriched fraction. Analysis of cell-free fetal (cff) DNA present in maternal plasma by RT-PCR using SRY primers and probes had previously established that at least one of the two fetuses was male. Then use RosetteSep TM Human mesenchymal stem cell enrichment mix reagent (Stemcell Technologies) and density gradient centrifugation were used to select fetal cells by negative selection of the nucleated cell enrichment fraction according to the target nucleated cell enrichment strategy in section 5.5.2.

[0191] The resulting cell population was then cultured according to the cell culture strategy in section 5.5.3. On day 3, cell culture supernatants were harvested and fluorescently labeled with a fluorescently-tagged anti-CD45 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Heightaaaaaaaaaa
Heightaaaaaaaaaa
Heightaaaaaaaaaa
Login to view more

Abstract

The present invention provides processes for isolating target nucleated cells, such as fetal mesenchymal stem cells, from non-nucleated red blood cells, populations of cells obtainable by the processes of the invention, and methods of using isolated targeted nucleated cells and their progeny for detecting fetal abnormalities and stem cell therapy.

Description

[0001] 1. Cross references to related applications [0002] This application claims priority to US Provisional Application No. 62 / 319,523, filed April 7, 2016, the contents of which are incorporated herein by reference in their entirety. 2. Background technology [0003] Recovery of nucleated cells (NC) circulating in peripheral blood (e.g., fetal cells circulating in maternal blood, cancer cells circulating in the blood of patients in clinical remission, stem cells, endothelial cells, and / or other very rare cells ) is the very low total number of these cells in a single blood collection. [0004] The first challenge in obtaining NC is that the number of anucleated red blood cells (RBC) in peripheral and non-peripheral blood exceeds that of much needed NC. For example, the number of fetal cells per 1 ml of maternal blood is 2-6, which is the ratio of 1 fetal cell in 1,000,000-3,000,000 nucleated maternal cells, and 1 fetal cell in 1,000,000,000-2,000,000,000 red blood cells. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/078A61B5/15G01N15/05G01N33/49
CPCC12N5/0087A61K35/28C12N5/0662C12Q1/6883C12Q2600/156
Inventor G·斯塔尔
Owner MESOTEX INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap